Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001397963 | SCV001599725 | likely benign | not provided | 2023-10-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004952863 | SCV005469239 | uncertain significance | Inborn genetic diseases | 2024-10-16 | criteria provided, single submitter | clinical testing | The c.6454C>A (p.H2152N) alteration is located in exon 41 (coding exon 41) of the PIEZO2 gene. This alteration results from a C to A substitution at nucleotide position 6454, causing the histidine (H) at amino acid position 2152 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |